Correction of β-thalassemia mutant by base editor in human embryos.
10.1007/s13238-017-0475-6
- Author:
Puping LIANG
1
;
Chenhui DING
2
;
Hongwei SUN
1
;
Xiaowei XIE
1
;
Yanwen XU
2
;
Xiya ZHANG
1
;
Ying SUN
1
;
Yuanyan XIONG
1
;
Wenbin MA
1
;
Yongxiang LIU
2
;
Yali WANG
2
;
Jianpei FANG
3
;
Dan LIU
4
;
Zhou SONGYANG
5
;
Canquan ZHOU
6
;
Junjiu HUANG
7
Author Information
1. Key Laboratory of Gene Engineering of the Ministry of Education, Guangzhou Key Laboratory of Healthy Aging Research and State Key Laboratory of Biocontrol, SYSU-BCM Joint Research Center, School of Life Sciences, Sun Yat-sen University, Guangzhou, 510275, China.
2. Key Laboratory of Reproductive Medicine of Guangdong Province, School of Life Sciences and the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510275, China.
3. Department of Pediatrics, Second Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510120, China.
4. Verna and Marrs Mclean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX, 77030, USA.
5. Key Laboratory of Gene Engineering of the Ministry of Education, Guangzhou Key Laboratory of Healthy Aging Research and State Key Laboratory of Biocontrol, SYSU-BCM Joint Research Center, School of Life Sciences, Sun Yat-sen University, Guangzhou, 510275, China. songyanz@mail.sysu.edu.cn.
6. Key Laboratory of Reproductive Medicine of Guangdong Province, School of Life Sciences and the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510275, China. zhoucanquan@hotmail.com.
7. Key Laboratory of Gene Engineering of the Ministry of Education, Guangzhou Key Laboratory of Healthy Aging Research and State Key Laboratory of Biocontrol, SYSU-BCM Joint Research Center, School of Life Sciences, Sun Yat-sen University, Guangzhou, 510275, China. hjunjiu@mail.sysu.edu.cn.
- Publication Type:Journal Article
- Keywords:
HBB −28 (A>G);
base editor;
human embryo;
β-thalassemia
- MeSH:
APOBEC-1 Deaminase;
genetics;
metabolism;
Base Sequence;
Blastomeres;
cytology;
metabolism;
CRISPR-Cas Systems;
Embryo, Mammalian;
metabolism;
pathology;
Female;
Fibroblasts;
metabolism;
pathology;
Gene Editing;
methods;
Gene Expression;
HEK293 Cells;
Heterozygote;
Homozygote;
Humans;
Point Mutation;
Primary Cell Culture;
Promoter Regions, Genetic;
Sequence Analysis, DNA;
beta-Globins;
genetics;
metabolism;
beta-Thalassemia;
genetics;
metabolism;
pathology;
therapy
- From:
Protein & Cell
2017;8(11):811-822
- CountryChina
- Language:English
-
Abstract:
β-Thalassemia is a global health issue, caused by mutations in the HBB gene. Among these mutations, HBB -28 (A>G) mutations is one of the three most common mutations in China and Southeast Asia patients with β-thalassemia. Correcting this mutation in human embryos may prevent the disease being passed onto future generations and cure anemia. Here we report the first study using base editor (BE) system to correct disease mutant in human embryos. Firstly, we produced a 293T cell line with an exogenous HBB -28 (A>G) mutant fragment for gRNAs and targeting efficiency evaluation. Then we collected primary skin fibroblast cells from a β-thalassemia patient with HBB -28 (A>G) homozygous mutation. Data showed that base editor could precisely correct HBB -28 (A>G) mutation in the patient's primary cells. To model homozygous mutation disease embryos, we constructed nuclear transfer embryos by fusing the lymphocyte or skin fibroblast cells with enucleated in vitro matured (IVM) oocytes. Notably, the gene correction efficiency was over 23.0% in these embryos by base editor. Although these embryos were still mosaic, the percentage of repaired blastomeres was over 20.0%. In addition, we found that base editor variants, with narrowed deamination window, could promote G-to-A conversion at HBB -28 site precisely in human embryos. Collectively, this study demonstrated the feasibility of curing genetic disease in human somatic cells and embryos by base editor system.
